Drug Name |
Cinacalcet |
Drug ID |
BADD_D02434 |
Description |
Cinacalcet is a calcimimetic sold by Amgen under the trade name Sensipar? in North America and Australia and as Mimpara? in Europe. It is used to treat hyperparathyroidism due to parathyroid tumours or renal failure. |
Indications and Usage |
For the treatment of secondary hyperparathyroidism in patients with Chronic Kidney Disease who are on hemodialysis or peritoneal dialysis. Also for the treatment of hypercalcemia in patients with parathyroid carcinoma. |
Marketing Status |
Not Available |
ATC Code |
H05BX01 |
DrugBank ID |
DB01012
|
KEGG ID |
D03504
|
MeSH ID |
D000069449
|
PubChem ID |
156419
|
TTD Drug ID |
D03YGR
|
NDC Product Code |
51407-297; 43598-368; 42291-461; 72865-152; 50268-153; 47335-379; 42291-459; 65162-213; 16714-079; 31722-104; 63629-8763; 42291-460; 64380-885; 67877-505; 68180-227; 68180-228; 72865-151; 65162-155; 16729-440; 63629-8765; 43598-367; 31722-103; 16714-080; 31722-105; 16729-441; 69097-410; 60687-525; 69097-412; 16714-078; 65862-831; 72865-150; 65862-833; 47335-380; 69097-411; 47335-600; 76282-676; 51407-296; 42543-961; 0904-7067; 65862-832; 76282-674; 64380-883; 64380-884; 42543-962; 43598-369; 51407-295; 67877-503; 67877-504; 42543-963; 68180-226; 76282-675; 65162-157; 63629-8764; 16729-442 |
Synonyms |
Cinacalcet | Cinacalcet Hydrochloride | Alpha-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphaR)-hydrochloride | Sensipar | AMG 073 | KRN 1493 | AMG073 |